ArticleFrontiers in oncology2020

Using Machine Learning Modeling to Explore New Immune-Related Prognostic Markers in Non-Small Cell Lung Cancer.

Jiasheng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.